Pfizer is rolling out wide area network optimisation technology for a series of 30-day trials across sites in India, Costa Rica, South Africa, Romania and the US. The numbers of users at these sites range from 75 to 10,000. Feedback from end-users has been key.

In this podcast, based on a presentation at the Burton Group Catalyst conference in October, Ron Rapp, associate director in Pfizer's worldwide technology engineering division discusses the approach the company has taken.